These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22862735)

  • 1. Association between glycemic control and hip fracture.
    Puar TH; Khoo JJ; Cho LW; Xu Y; Chen YT; Chuo AM; Poh CB; Ng JM
    J Am Geriatr Soc; 2012 Aug; 60(8):1493-7. PubMed ID: 22862735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycated Hemoglobin Level and Risk of Hip Fracture in Older People with Type 2 Diabetes: A Competing Risk Analysis of Taiwan Diabetes Cohort Study.
    Li CI; Liu CS; Lin WY; Meng NH; Chen CC; Yang SY; Chen HJ; Lin CC; Li TC
    J Bone Miner Res; 2015 Jul; 30(7):1338-46. PubMed ID: 25598134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HbA1c variability, in addition to mean HbA1c, predicts incident hip fractures in Chinese people with type 2 diabetes.
    Lui DTW; Lee CH; Chan YH; Chow WS; Fong CHY; Siu DCW; Tse HF; Woo YC; Lam KSL
    Osteoporos Int; 2020 Oct; 31(10):1955-1964. PubMed ID: 32385660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Glycated Hemoglobin in Frail Older Diabetic Patients With Hip Fracture.
    Paterni S; Okoye C; Calabrese AM; Niccolai F; Polini A; Caraccio N; Calsolaro V; Monzani F
    Front Endocrinol (Lausanne); 2021; 12():770400. PubMed ID: 34867813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database.
    Bae JP; Duan R; Fu H; Hoogwerf BJ
    Clin Ther; 2017 Sep; 39(9):1790-1798.e7. PubMed ID: 28781218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic Control and Insulin Treatment Alter Fracture Risk in Older Men With Type 2 Diabetes Mellitus.
    Lee RH; Sloane R; Pieper C; Lyles KW; Adler RA; Van Houtven C; LaFleur J; Colón-Emeric C
    J Bone Miner Res; 2019 Nov; 34(11):2045-2051. PubMed ID: 31269274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China.
    Bi Y; Zhu D; Cheng J; Zhu Y; Xu N; Cui S; Li W; Cheng X; Wang F; Hu Y; Shen S; Weng J
    Clin Ther; 2010 May; 32(5):973-83. PubMed ID: 20685506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Intensive Glycemic Management in Older Adults with Diabetes Mellitus.
    Arnold SV; Lipska KJ; Wang J; Seman L; Mehta SN; Kosiborod M
    J Am Geriatr Soc; 2018 Jul; 66(6):1190-1194. PubMed ID: 29633237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiabetic Treatment, Level of Glycemic Control, and Risk of Fracture in Type 2 Diabetes: a Nested, Case-Control Study.
    Charlier S; Vavanikunnel J; Becker C; Jick SS; Meier C; Meier CR
    J Clin Endocrinol Metab; 2021 Jan; 106(2):554-566. PubMed ID: 33141149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of type 2 diabetes-related characteristics with fracture risk at different sites.
    van Hulten V; Souverein PC; Starup-Linde J; Viggers R; Klungel OH; Vestergaard P; Brouwers MCJG; van den Bergh JP; Driessen JHM
    Diabetes Obes Metab; 2024 Nov; 26(11):4887-4896. PubMed ID: 39223858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes.
    McCoy RG; Lipska KJ; Van Houten HK; Shah ND
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32075810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control.
    Lipska KJ; Ross JS; Miao Y; Shah ND; Lee SJ; Steinman MA
    JAMA Intern Med; 2015 Mar; 175(3):356-62. PubMed ID: 25581565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality after hip fracture in diabetic patients.
    Gulcelik NE; Bayraktar M; Caglar O; Alpaslan M; Karakaya J
    Exp Clin Endocrinol Diabetes; 2011 Jul; 119(7):414-8. PubMed ID: 21553363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of long-term glycemic control as measured by glycated hemoglobin with serum angiopoietin-like 6 protein levels in type 2 diabetes mellitus patients.
    Sharma V; Pangtey GS; Gupta R; Rehan HS; Gupta LK
    Indian J Pharmacol; 2017; 49(3):250-253. PubMed ID: 29033485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
    Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
    JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic and non-glycemic targets in younger and older North Indian subjects with type 2 diabetes in a Tertiary care hospital: A 10 year's retrospective data analysis.
    Ahmad J; Zubair M; Malik N; D Z; Raghav A
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S130-4. PubMed ID: 26564028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Glycemic Control and Risk of Fracture in Diabetic Patients: A Nested Case-Control Study.
    Vavanikunnel J; Charlier S; Becker C; Schneider C; Jick SS; Meier CR; Meier C
    J Clin Endocrinol Metab; 2019 May; 104(5):1645-1654. PubMed ID: 30657918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes.
    Zeitler P; Hirst K; Copeland KC; El Ghormli L; Levitt Katz L; Levitsky LL; Linder B; McGuigan P; White NH; Wilfley D;
    Diabetes Care; 2015 Dec; 38(12):2285-92. PubMed ID: 26537182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.
    Josse RG; Majumdar SR; Zheng Y; Adler A; Bethel MA; Buse JB; Green JB; Kaufman KD; Rodbard HW; Tankova T; Westerhout CM; Peterson ED; Holman RR; Armstrong PW;
    Diabetes Obes Metab; 2017 Jan; 19(1):78-86. PubMed ID: 27607571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.